HYPERION DEFI, INC. HYPD
We were organized as a corporation under the laws of the State of Florida on March 12, 2014 under the name "PGP Holdings V, Inc." On May 5, 2014, we changed our name to Eyenovia, Inc. On October 6, 2014, we reincorporated in the State of Delaware by merging into Eyenovia, Inc., a Delaware corporation. On July 1, 2025, we changed our name to Hyperion DeFi, Inc. Our principal executive office is located at 23461 S. Pointe Drive, Suite 390, Laguna Hills, CA 92653, and our telephone number is (833) 393-6684. We maintain a website at www.hyperiondefi.com, to which we regularly post copies of our press releases as well as additional information about us. The information contained on, or that can be accessed through, our website is not a part of this report. We have included our website address in this report solely as an inactive textual reference.
Valuation FY2025 figures against the last close
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $813.5K | $57.3K | $3.8K | — | $14.0M | $2.0M | — | — | — | — |
| Cost of revenue | $303.3K | $3.9M | $16.0K | — | $1.6M | $800.0K | — | — | — | — |
| Gross profit | $510.2K | -$3.9M | -$12.2K | — | $12.4M | $1.2M | — | — | — | — |
| R&D | $1.9M | $14.5M | $13.0M | $13.4M | $14.9M | $13.4M | $14.1M | $11.1M | $3.8M | $3.0M |
| SG&A | $17.2M | $14.3M | $12.4M | $13.5M | $10.6M | $7.6M | $7.2M | $6.1M | $1.3M | $568.8K |
| Total operating expenses | $47.2M | $44.9M | $25.4M | $26.9M | $25.4M | $21.0M | $21.3M | $17.3M | $5.1M | $3.5M |
| Operating income | -$46.7M | -$48.7M | -$25.4M | -$26.9M | -$13.0M | -$19.8M | -$21.3M | -$17.3M | -$5.1M | -$3.5M |
| Interest expense | $1.6M | $2.5M | $2.4M | $1.4M | $387.8K | $17.0K | — | — | — | — |
| Pre-tax income | -$45.3M | — | — | — | — | — | -$21.2M | -$17.3M | -$5.1M | -$3.5M |
| Income tax | $30.9K | — | — | — | — | — | $0 | $0 | $0 | $0 |
| Net income | -$45.3M | -$49.8M | -$27.3M | -$28.0M | -$12.8M | -$19.8M | -$21.2M | -$17.3M | -$5.1M | -$3.5M |
| EPS, basic | -9.40 | -59.81 | -53.15 | -0.83 | -0.49 | -0.94 | — | — | — | — |
| EPS, diluted | -9.40 | -59.81 | -53.15 | -0.83 | -0.49 | -0.94 | -1.47 | -1.82 | -2.19 | -1.56 |
| Shares, diluted (wtd. avg.) | 5.0M | 832,997 | 512,912 | 33.6M | 26.3M | 21.1M | — | — | — | — |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $6.4M | $2.1M | $14.8M | $22.9M | $27.3M | $28.4M | $14.2M | $19.7M | $5.2M | $3.4M |
| Inventory | — | — | $109.8K | — | — | — | — | — | — | — |
| Total current assets | $7.2M | $2.8M | $20.7M | $27.6M | $22.0M | $33.4M | $14.3M | $19.9M | $5.3M | $3.4M |
| Property, plant and equipment | — | — | $3.4M | $1.3M | $1.3M | $396.4K | $230.5K | $36.7K | $28.0K | $43.2K |
| Other intangibles | — | — | $2.1M | — | — | — | — | — | — | — |
| Total assets | $51.8M | $3.7M | $28.8M | $31.0M | $31.7M | $33.9M | $14.7M | $20.0M | $5.6M | $3.4M |
| Accounts payable | $317.9K | $2.0M | $1.8M | $1.4M | $1.6M | $1.5M | $1.5M | $1.5M | $246.4K | $302.0K |
| Total current liabilities | $2.7M | $16.0M | $9.5M | $4.5M | $11.2M | $18.2M | $2.9M | $3.1M | $552.6K | $423.7K |
| Total liabilities | $10.7M | $16.8M | $19.8M | $13.8M | $11.2M | $18.6M | $3.0M | $3.1M | $552.6K | — |
| Retained earnings | -$240.6M | -$195.3M | -$145.5M | -$118.2M | -$90.2M | -$77.4M | -$57.7M | -$36.5M | -$19.3M | -$14.1M |
| Total equity | $41.1M | -$13.1M | $9.0M | $17.2M | $20.5M | $15.3M | $11.7M | $16.9M | $5.1M | $3.0M |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$14.8M | -$30.1M | -$23.8M | -$25.1M | -$20.9M | -$6.4M | -$18.9M | -$13.1M | -$4.7M | -$3.2M |
| Depreciation and amortisation | — | $1.1M | $783.2K | $307.4K | $221.6K | $95.4K | $15.3K | $19.1K | $25.5K | $12.8K |
| Stock-based compensation | $6.4M | $1.7M | $2.5M | $3.8M | $2.9M | $2.5M | $2.5M | $1.6M | $412.3K | $2.7K |
| Capital expenditure | — | $161.5K | $2.8M | $540.4K | $1.2M | $261.3K | $166.6K | $27.9K | $10.2K | $43.1K |
| Investing cash flow | -$72.0M | -$161.5K | -$4.0M | -$874.7K | -$1.6M | -$261.3K | -$166.6K | -$27.9K | -$10.2K | -$43.1K |
| Financing cash flow | $91.0M | $17.6M | $19.8M | $21.5M | $21.5M | $20.9M | $13.5M | $27.6M | $6.6M | $4.1M |
| Buybacks | $253.6K | — | — | — | — | — | — | — | — | — |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001104659-26-055725.
Plot the figures US dollars
- Revenue
- Gross profit
- Net income
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | $2.0M | $14.0M | — | $3.8K | $57.3K | $813.5K |
| Gross profit | — | — | — | — | $1.2M | $12.4M | — | -$12.2K | -$3.9M | $510.2K |
| Net income | -$3.5M | -$5.1M | -$17.3M | -$21.2M | -$19.8M | -$12.8M | -$28.0M | -$27.3M | -$49.8M | -$45.3M |
Recent filings and events
- Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
- Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
- Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
- Shareholder vote The results of the annual meeting or a special vote. Item 5.07
- Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
- Results announced Item 2.02
- Regulation FD disclosure Item 7.01
- Other event Item 8.01
- Other event Item 8.01
- Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
- Results announced Item 2.02
- Charter or fiscal year changed A change to the company's governing documents, or to when its year ends. Item 5.03
Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.
Others in SIC 2834
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| LLY | ELI LILLY & Co | $1.20T | 55.5x | 44.7% |
| JNJ | JOHNSON & JOHNSON | $635.76B | 23.9x | 6.0% |
| ABBV | AbbVie Inc. | $504.76B | 121.0x | 8.6% |
| MRK | Merck & Co., Inc. | $358.41B | 20.0x | 1.3% |
| ABT | ABBOTT LABORATORIES | $180.63B | 27.9x | 5.7% |
| PFE | PFIZER INC | $171.16B | 22.1x | -1.6% |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | $132.80B | 34.2x | 8.9% |
| BMY | BRISTOL MYERS SQUIBB CO | $125.59B | 17.8x | -0.2% |